Pharmacy Technicians Initially Hesitant About Administering Vaccines
January 31st 2022Ashley Woodyard, a PharmD candidate at the Touro University California College of Pharmacy in Vallejo and co-author of an article in the January 2022 issue of Pharmacy Times®, discussed the article and the benefits of pharmacy technicians as vaccine administrators.
Watch
ASHP Discusses Grant Received From American Rescue Plan
January 28th 2022Anna Legreid Dopp, PharmD, the Senior Director of Clinical Guidelines & Quality Improvement at ASHP, and Bayli Larson, PharmD, the Strategic Initiatives Associate at ASHP, discuss the grant the ASHP received from the American Rescue Plan.
Watch
Pharmacist Medication Insights: Abemaciclib (Verzenio) for Breast Cancer
January 28th 2022Abemaciclib (Verzenio) was recently approved in combination with endocrine therapy for the adjuvant treatment of adult patients with HR–positive, HER2-negative, node-positive, early breast cancer at high risk of recurrence.
Watch
Expert: Mark Cuban Cost Plus Drug Company Raises Questions, But May Not Be Cause for Concern
January 27th 2022Ron Lanton III, Esq, principal at Lanton Law, said entrepreneur Mark Cuban's new venture into the pharmacy field is very interesting, although it maybe just another player in the mail-order pharmacy market.
Watch
Is a 90-Day Supply the Best Option to Improve Medication Adherence?
Interventions to improve medication adherence may have a greater impact on individual patients and the population as a whole than any novel treatment or therapy.
Read More
Pfizer, BioNTech to Evaluate Omicron-Based COVID-19 Vaccine in Adults 18 to 55 Years of Age
January 27th 2022The study will have 3 cohorts examining different regimens of the current Pfizer-BioNTech COVID-19 vaccine or an omicron-based vaccine and will use participants from the phase 3 COVID-19 booster study.
Read More